Polymorphism of the DRD2 Gene in a Mexican Population with Mental Deviations

被引:0
作者
M. Salas-Magaña
C. A. Tovilla-Zárate
A. Genis
T. B. González-Castro
I. E. Juárez-Rojop
M. L. López-Narvaez
机构
[1] División Académica de Ciencias de la Salud,Universidad Juárez Autónoma de Tabasco
[2] Universidad Juárez Autónoma de Tabasco,División Académica Multidisciplinaria de Comalcalco
[3] Secretaría de Salud,Instituto Nacional de Medicina Genómica (INMEGEN), Servicios de Atención Psiquiátrica (SAP)
[4] Universidad Juárez Autónoma de Tabasco,División Académica Multidisciplinaria de Jalpa de Méndez
[5] Secretaría de Salud,Hospital General de Yajalón
来源
Neurophysiology | 2018年 / 50卷
关键词
dopamine; gene; alleles; polymorphism; mental deviations;
D O I
暂无
中图分类号
学科分类号
摘要
The important functions of dopamine (DA) in emotional behavior, control of voluntary movements, memory, and attention have been recognized. To date, the 939 C/T (rs6275) polymorphism of this gene has been implicated in association with alcohol and drug abuse and also with schizophrenia. We examined the allele frequencies of 939CT (rs6275) polymorphism of the DRD2 gene and those of the respective genotypes in a Mexican population (n = 166) with mental deviations and a history of suicide attempts and psychiatric diagnoses (101 suicidal individuals from Mexico City and 65 patients recruited from psychiatry outpatients of Tabasco, México). The most common allele found in both subpopulations was the T allele (about 60% and 69%, respectively). In addition to the Mexican population, the frequencies were compared with those in some Asian and American populations. Thus, a noticeable difference of the distribution of the 939 C/T (rs6275) was observed in patients with the above-mentioned mental deviations, as well as in the Asian population with a diagnosis of schizophrenia. Future studies are necessary to evaluate mentally unhealthy populations to observe the role of the above polymorphism in the susceptibility to psychiatric diseases.
引用
收藏
页码:254 / 258
页数:4
相关论文
共 42 条
  • [1] Yeragani VK(2010)Arvid Carlsson, and the story of dopamine Indian J. Psychiatry 52 87-88
  • [2] Tancer M(2015)Dopamine receptors – IUPHAR Review 13 Br. J. Pharmacol. 172 1-23
  • [3] Chokka P(2015)Dopamine D2-receptor blockade enhances decoding of prefrontal signals in humans J. Neurosci. 35 4104-4111
  • [4] Baker GB(2005)Association of multiple DRD2 polymorphisms with Neuropsychopharmacology 30 1703-1710
  • [5] Beaulieu JM(2017)Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor Pharmacol. Rep. 69 235-241
  • [6] Espinoza S(2016)Association between dopamine D2 receptor gene polymorphisms and the risk of heroin dependence Genet. Mol. Res. 4 15-536
  • [7] Gainetdinov RR(2013)The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems Addict. Biol. 18 523-79
  • [8] Kahnt T(2017)Impact of DRD2/ANKK1 and COMT polymorphisms on attention and cognitive functions in schizophrenia PloS One 12 e0170147-73
  • [9] Weber SC(2011)Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women Psychiatry Res 187 74-56
  • [10] Haker H(2013)Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility Neuromol. Med. 15 61-1239